The American Academy of Pediatrics is splitting from the federal government in its recommendations on which children should ...

Beyfortus (nirsevimab) is the only option that can offer RSV protection designed for all infants with proven high, sustained efficacy, favourable safety and public health impact demonstrated in the ...

The American Academy of Pediatrics released its vaccine schedule on Aug 19, which differs from the guidance provided by ...

A new study shows that while RSV mostly affects younger kids, the often-overlooked human metapneumovirus also hospitalizes ...

The CDC expanded RSV vaccine recommendations to include adults aged 50 and above who have underlying health conditions ...

The American Academy of Pediatrics on Tuesday recommended that all infants get vaccinated against COVID-19, deviating from ...

“We’ve stepped back into the world that we lived in before the [CDC’s vaccine advisory committee] was created,” said Dr.

After receiving FDA approval in 2023, the first over-the-counter birth control pills in the U.S. hit shelves last spring. A ...

The American Academy of Pediatrics recommends all children ages 6 months to 23 months old receive a coronavirus vaccine as ...

Research and Development Expenses-- $4,700,000 compared to $5,600,000 during the prior year comparable period. Kodiak PCR ...

Invivyd ( ($IVVD) ) just unveiled an update. On August 14, 2025, Invivyd announced its alignment with the U.S. FDA on a rapid pathway to full ...

British drugmaker GSK said on Monday that the U.S. Food and Drug Administration has accepted its application for priority ...